Telix Pharmaceuticals | TLX - Trade Creditors

Stock Price
10.08
Daily Change
-0.13 -1.23%
Monthly
-13.52%
Yearly
-64.60%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD71.66M in Trade Creditors for its fiscal semester ending in December of 2025.





Trade Creditors Change Date
Cochlear AUD 298.4M 12.9M Jun/2025
CSL USD 3.46B 484M Jun/2025
Integral Diagnostics AUD 28.28M 17.87M Dec/2023
Mayne Pharma AUD 30.25M 2.99M Jun/2025
Medical Developments International AUD 6.49M 1.35M Jun/2025
Mesoblast USD 19.08M 7.22M Jun/2025
Neuren Pharmaceuticals AUD 6.66M 5.21M Jun/2025
Pacific Edge NZD 5.45M 2.6M Dec/2025
Paradigm Biopharmaceuticals AUD 2.73M 2.15M Jun/2025
Polynovo AUD 6.39M 2.84M Jun/2024
PYC Therapeutics AUD 8.75M 1.17M Jun/2025
Ramsay Health Care AUD 1.73B 76.3M Jun/2025
ResMed USD 250.41M 16.36M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024